John Divine

John Divine

John Divine is currently an investing reporter at U.S. News & World Report, and was previously an assistant editor at InvestorPlace.com. He has worked variously in the fields of commercial real estate, money management and digital media, working as a financial journalist for most of his professional career.

John has also been a regular contributor to The Motley Fool, and his work also has appeared on AOL DailyFinance.

In 2013, he shortened his bucket list when he saw Warren Buffett live and in the flesh while covering the Berkshire Hathaway Annual Shareholders’ Meeting.

A proud North Carolinian and graduate of Appalachian State University, John majored in Finance & Banking. He enjoys basketball, reading, writing and food. He does not care for the Oxford comma, and he does not require the food he enjoys to be nutritious.

Recent Articles

3 Simple Reasons the MannKind (MNKD) Stock Rally Will Last

MannKind (MNKD) stock is on a ferocious rally. And given the bullish outlook for Afrezza, as well as strong technicals, I expect the rally to last.

Eleven Biotherapeutics (EBIO) Stock Roller Coaster Continues With 70% Selloff

Eleven Biotherapeutics (EBIO) stock lost 70% today after its dry-eyes drug EBI-005 failed to beat the control group in a Phase 3 study. Can EBIO recover?

3 Biggest Warren Buffett Portfolio Moves in Q1

The Warren Buffett portfolio doesn't change frequently, but the Oracle of Omaha increased (or decreased) his stake in these 3 stocks by at least 30%.

Income Inequality Is Surging — Mostly Because of the Stock Market

The numbers are in, and there's no two ways about it: The stock market is the core cause of income inequality in the U.S.

Beware King Digital (KING) Stock – It’s a Value Trap

KING stock is trading lower on Friday, even after KING earnings topped estimates. It was guidance that doomed the Candy Crush developer.

Netflix in China: A Huge Opportunity for NFLX Stock

Hello Netflix China? NFLX stock surges on news the company plans on bringing its streaming service to China.

Timeline: How Avon Stock Went Berserk on Fake Buyout Bid (AVP)

The Avon (AVP) stock price went bonkers today, as a phony SEC filing caused investors to believe there was an $18.75/share buyout offer. There wasn't.

The 10 Most Popular Brands on Facebook

What are the most popular brands on Facebook? The brands with the most Facebook likes have tens of millions of fans each; some will surprise you.

Zillow (Z) Earnings: I’ve Had Better

Zillow (Z) stock reported earnings after the bell on Tuesday, and Wall Street is punishing Z stock on Wednesday ... deservedly.

AVOID Orexigen (OREX) Stock After Contrave Study SNAFU

The Orexigen (OREX) stock price plummeted Wednesday after the Contrave study was cancelled due to the improper disclosure of data points. Yikes.